Addressing the Global Threat of Antimicrobial Resistance (AMR)

Share this article:

NPS-ALL-NP-00726 November 2022

Find out more

Learn more about Teva’s involvement in the AMR Action Fund
Explore how we’re making an impact through Environmental, Social and Governance (ESG) across Teva in our annual ESG Progress Report
Interested in getting involved in the work that we do? Explore a career at Teva

You might also be interested

Respiratory
Sustainability
Neuroscience

Living With an Invisible Disability: What We All Need to Know

Access to Medicine
Sustainability

Spreading HOPE: Teva’s Work to Improve Global Access to Medicine

Medical specialists at work, consulting with the goal of improving patient safety.

Our People
Patient Focus

Medical Specialists We All Need but Never See: Safety Physicians

Environment
Sustainability

Teva Named One of the World’s Most Sustainable Companies

Eric Hughes, Chief Medical Officer giving a speech

Leadership
Innovation
Patient Focus

How Can We Use AI to Make Medicines More Efficiently?

Environment
Sustainability

Going Green for Greater Health

Leadership
Patient Focus
Research & Development
Innovation

Can AI-driven digital biomarkers redefine diagnostics and clinical trials?

Teva’s German Fleet is Reducing CO2 Emissions

Environment
Sustainability

How Teva’s German Fleet is Reducing CO2 Emissions by 30%

Teva employees collaborating

Innovation
Patient Focus

7 Ways Teva is Collaborating to Innovate

Sustainability

Teva Expands Partnership to Bring Critical Medicines to Children Living with Cancer